Latest News
11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences...
Moving from Push to Pull
Nothing less than an entirely new model of drug development is needed if we are to create new antibiotics says Dr Peter Jackson. And it’s something NICE are finally taking seriously as they set about developing a ne...
This week is World Antibiotic Awareness Week.
Watch the video produced by the AMR Centre here:
Alderley Park, UK, 11 November 2019 The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).
The MBL inhibitor (MBLI) research...
We are delighted to share that Nexus Labs has been selected for the prestigious Accelerator Programme at Alderley Park, powered by BioCity. represented by CEO Glyn Estebanez, Nexus will be one of 7 high-potential life-sciences start-ups...